Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Sci Rep ; 14(1): 3386, 2024 02 09.
Article in English | MEDLINE | ID: mdl-38336807

ABSTRACT

During the COVID pandemic caused by the SARS-CoV-2 virus, studies have shown the efficiency of deactivating this virus via ultraviolet light. The damage mechanism is well understood: UV light disturbs the integrity of the RNA chain at those locations where specific nucleotide neighbors occur. In this contribution, we present a model to address certain gaps in the description of the interaction between UV photons and the RNA sequence for virus inactivation. We begin by exploiting the available information on the pathogen's morphology, physical, and genomic characteristics, enabling us to estimate the average number of UV photons required to photochemically damage the virus's RNA. To generalize our results, we have numerically generated random RNA sequences and checked that the distribution of pairs of nucleotides susceptible of damage for the SARS-CoV-2 is within the expected values for a random-generated RNA chain. After determining the average number of photons reaching the RNA for a preset level of fluence (or photon density), we applied the binomial probability distribution to evaluate the damage of nucleotide pairs in the RNA chain due to UV radiation. Our results describe this interaction in terms of the probability of damaging a single pair of nucleotides, and the number of available photons. The cumulative probability exhibits a steep sigmoidal shape, implying that a relatively small change in the number of affected pairs may trigger the inactivation of the virus. Our light-RNA interaction model quantitatively describes how the fraction of affected pairs of nucleotides in the RNA sequence depends on the probability of damaging a single pair and the number of photons impinging on it. A better understanding of the underlying inactivation mechanism would help in the design of optimum experiments and UV sanitization methods. Although this paper focuses on SARS-CoV-2, these results can be adapted for any other type of pathogen susceptible of UV damage.


Subject(s)
COVID-19 , Viruses , Humans , SARS-CoV-2/genetics , Ultraviolet Rays , RNA , Virus Inactivation , Nucleotides , Disinfection/methods
2.
Langmuir ; 28(24): 8891-901, 2012 Jun 19.
Article in English | MEDLINE | ID: mdl-22369236

ABSTRACT

A comparative study of different plasmonic nanoparticles with different morphologies (nanospheres and triangular nanoprisms) and metals (Ag and Au) was done in this work and applied to the ultrasensitive detection of aminoglutethimide (AGI) drug by surface enhanced Raman spectroscopy (SERS) and plasmon resonance. AGI is an aromatase inhibitor used as an antitumoral drug with remarkable pharmacological interest and also in illegal sport doping. The application of very sensitive spectroscopic techniques based on the localization of an electromagnetic field on plasmonic nanoparticles confirms the previous study of the adsorption of drugs onto a metal surface due to the near field character of these techniques. The adsorption of AGI on the above substrates was investigated at different pH values and surface coverages, and the results were analyzed on the basis of AGI/metal affinity, considering the interaction mechanism, the existence of two binding sites in AGI, and the influence of the interface on the adsorption in terms of surface charge due to the presence of other ions linked to the surface. Finally, a comparative quantitative detection of AGI was performed on both spherical and triangular nanoprism nanoparticles, and a limit of detection lower than those reported so far was deduced on the latter nanoparticles.


Subject(s)
Aminoglutethimide/analysis , Doping in Sports , Gold/chemistry , Metal Nanoparticles/chemistry , Silver/chemistry , Surface Plasmon Resonance , Adsorption , Particle Size , Spectrum Analysis, Raman , Surface Properties
SELECTION OF CITATIONS
SEARCH DETAIL